COME SEE US AT CPHI 2023, CONTACT US FOR MORE INFORMATION
GLOBAL PHARMAPARTNERS, INC YOUR BEST BUSINESS PARTNER FOR PHARMACEUTICAL SUCCESS!
Announcing: Tofacitinib Extended-Release Tablets - SUCCESSFUL BIOS!!!
GPP's Development Partner has developed Tofacitinib Extended Release Tablets USP, 11mg & 22 mg generic for XELJANZ XR (Tofacitinib citrate). We have successfully completed the U.S. pilot biostudy. Compete File ready for filing with FDA by May 2024. Also available for EU/UK/ROW. We have identified an FDA/EMA/MHRA inspected CMO and API. We are looking for US Commercial partner to take it forward. Please contact me at Robcamerer@globalpharmapartners.com or +1 (417) 770-4600
GPP has developed valuable relationships over the last thirty years and has direct access to over 500 generic pharmaceutical sales and marketing companies in the USA, Canada, Latin America, and globally. GPP takes pride in nurturing relationships with the TOP decision makers at these companies.
Global Locations & Network
4922 S. Eldon Avenue
Office: +1 (417) 885-7000
Mobile: +1 (417) 770-4600
New York, NY USA
Chicago, IL USA
Charlotte, NC USA
Our Expertise and Services
GPP Markets to more than 250+ US customers both online as well as annually at DCAT, CPHi, as well as other marketing events
GPP creates marketing materials for our partners for tradeshows and online campaigns
4922 S. Eldon Ave
Upcoming trade shows:
EuroPLX 75 Cascias/Lisbon Virtual
Please contact us to schedule a meeting